People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

126.10CHF
4 May 2015
Change (% chg)

-- (--)
Prev Close
CHF126.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
629,704
52-wk High
CHF127.90
52-wk Low
CHF82.00

Search Stocks

Franco, Nicholas 

Mr. Nicholas Franco has served as Member of the Management Board, Executive Vice President, Chief Business Development Officer at Actelion Ltd since 2011. He also serves as Senior Vice President, International Commercial Operations, at Axcan Pharma, France; Head of Market Access Region Europe for Novartis Pharma AG, Switzerland, where he held various management positions since 1991. Previous positions include President of Novartis Ophthalmics, Global Head, Business Development and Licensing Negotiations, and Global Head of Neuroscience Business Franchise. He is a Graduate of McGill University, Canada, with a BSc in Biochemistry and a Master’s degree in Business Administration, Strategic Planning and Marketing.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks